One of the most promising applications of Cyclosporine A in cancer treatment is its ability to counteract chemotherapy resistance. Cancer cells often develop resistance to multiple drugs by overexpressing P-glycoprotein, which pumps chemotherapeutic agents out of the cells. Cyclosporine A can inhibit this protein, thereby increasing the intracellular concentration of drugs and enhancing their efficacy.
